Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free IMUX Stock Alerts

Immunic (IMUX) Earnings Date, Estimates & Call Transcripts

Immunic logo
$16.06 -0.52 (-3.14%)
Closing price 04:00 PM Eastern
Extended Trading
$16.08 +0.02 (+0.15%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Immunic Earnings Summary

Immunic issued Q2 2026 earnings on August 11, 2026, reporting an EPS of -$0.80, which topped analysts' consensus estimates of -$1.16 by $0.36. With a trailing EPS of -$5.58, Immunic's earnings are expected to grow next year, from ($4.49) to ($4.06) per share.

Latest Q2
Earnings Date
Aug. 11Estimated
Consensus EPS
(Aug. 11)
-$1.16
Actual EPS
(Aug. 11)
-$0.80 Beat By $0.36

Q2 2026 Earnings Resources

Powered by Quartr
Get Immunic Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Immunic and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

IMUX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Immunic Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20266-$1.60-$0.20-$0.97
Q2 20267-$2.41-$0.80-$1.29
Q3 20267-$2.21-$0.60-$1.21
Q4 20267-$2.03-$0.50-$1.14

Immunic Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026-$1.16-$0.80+$0.36-$0.80--
5/13/2026Q1 2026-$0.71-$1.08 -$0.37-$1.08--
2/26/2026Q4 2025-$1.0222-$1.20 -$0.1778-$0.07--
11/13/2025Q3 2025-$1.80-$1.30+$0.50-$0.13--
8/7/2025Q2 2025-$1.80-$2.00 -$0.20-$0.20--
5/15/2025Q1 2025-$2.50-$2.50--$0.25--
11/7/2024Q3 2024-$2.20-$2.40 -$0.20-$0.24--

Immunic Earnings - Frequently Asked Questions

Immunic (NASDAQ:IMUX) last announced its quarterly earning data on Tuesday, August 11, 2026. Learn more on IMUX's earnings history.

In the previous quarter, Immunic (NASDAQ:IMUX) reported ($0.80) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.16) by $0.36. Learn more on analysts' earnings estimate vs. IMUX's actual earnings.

Immunic's earnings report can be found in their filing with the SEC.
View SEC filing

Immunic (NASDAQ:IMUX) has a recorded net income of -$97.17 million. IMUX has generated -$5.58 earnings per share over the last four quarters.

Immunic's earnings are expected to grow from ($4.41) per share to ($4.05) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:IMUX is sourced from Fiscal.ai, with the most recent quarter reported on 8/11/2026. New results are added as companies report their earnings.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
AI insiders stockpile guns, gold & gas masks
Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift...
TradeSmith | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Who Really Gets Rich from IPOs?
Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...
Weiss Ratings | Sponsoredtc pixel
$100 for this… $500 for that. Here’s how to stop the bleeding today
Rising costs are squeezing households nationwide. USA Today reports more families are moving in together, whil...
Brownstone Research | Sponsoredtc pixel